Thursday, 29 April 2021, 1:46 pm Health Navigator NZ has created new, plain language fact sheets that provide easy to understand information about the type 2 diabetes medicine Empagliflozin. The fact sheets have been developed in English, te reo Māori, Samoan and Tongan languages, providing clear, accurate information about Empagliflozin. The project is part of Health Navigator NZ’s ongoing commitment to helping improve health literacy and reduce health inequity. PHARMAC recently funded Empagliflozin (Jardiance) and Empagliflozin + metformin (Jardiamet) specifically for Māori and Pasifika. These groups are at a high risk of complications from type 2 diabetes, such as kidney and heart problems.